Inolimomab for Children with Steroid-Refractory Acute Graft-Versus‐Host Disease: A National Multicenter Phase II Retrospective Analysis

Ouachee-Chardin, Marie;Neven, Bénédicte;Lehert, Philippe;et.al.
(2012) European Society of Bone Marrow Transplantation days — Location: Geneva (15.April.2012)

Files

No attached file found for this publication.

Details

Authors
  • Ouachee-Chardin, Marie
    Author
  • Neven, Bénédicte
    Author
  • Lehert, Philippeorcid-logoUCLouvain
    Author
  • et. al.
Abstract
One hundred twenty-three children from 6 French centers were evaluated retrospectively for the treatment of steroid-refractory acute graft-versus-host disease (aGVHD) with Inolimomab, a murine anti-IL2R.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Ouachee-Chardin, M., Neven, B., Lehert, P., & et al. (2012). Inolimomab for Children with Steroid-Refractory Acute Graft-Versus‐Host Disease: A National Multicenter Phase II Retrospective Analysis. European Society of Bone Marrow Transplantation days, Geneva. https://hdl.handle.net/2078.5/185145